Recommendations

118
Smith et al. 2005
ACC/AHA/SCAI Practice Guidelines
ACC - www.acc.org
AHA - www.americanheart.org
SCAI - www.scai.org
update: a statement for healthcare professionals from the
American Heart Association and the American College of
Cardiology. Circulation 2001;104:1577-9.
811. Clark VL, Dolce J. Unplanned admissions after outpatient cardiac
catheterization. Clin Cardiol 1993;16:823-6.
812. Rozenman Y, Gilon D, Zelingher J, et al. One-stage coronary
angiography and angioplasty. Am J Cardiol 1995;75:30-3.
813. Adele C, Vaitkus PT, Wells SK, Zehnacker JB. Cost advantages of
an ad hoc angioplasty strategy. J Am Coll Cardiol 1998;31:321-5.
814. Breisblatt WM, Ruffner RJ, Uretsky BF, Reddy PS. Same-day
angioplasty and diagnostic catheterization: safe and effective but
riskier in unstable angina. Angiology 1991;42:607-13.
815. Deleted in press.
816. O’Keefe JHJ, Gernon C, McCallister BD, Ligon RW, Hartzler
GO. Safety and cost effectiveness of combined coronary angiography
and angioplasty. Am Heart J 1991;122:50-4.
817. O’Keefe JHJ, Reeder GS, Miller GA, Bailey KR, Holmes DR Jr.
Safety and efficacy of percutaneous transluminal coronary angioplasty
performed at time of diagnostic catheterization compared
with that performed at other times. Am J Cardiol 1989;63:27-9.
818. Kimmel SE, Berlin JA, Hennessy S, Strom BL, Krone RJ, Laskey
WK. Risk of major complications from coronary angioplasty performed
immediately after diagnostic coronary angiography:
results from the Registry of the Society for Cardiac Angiography
and Interventions. J Am Coll Cardiol 1997;30:193-200.
819. Goldstein CL, Racz M, Hannan EL. Impact of cardiac catheterization-percutaneous
coronary intervention timing on inhospital
mortality. Am Heart J 2002;144:561-7.
820. Alfonso F, Macaya C, Iniguez A, Zarco P. Repeat coronary angioplasty
during the same angiographic diagnosis of coronary
restenosis. Am Heart J 1990;119:237-41.
821. Myler RK, Stertzer SH, Clark DA, Shaw RE, Fishman-Rosen J,
Murphy MC. Coronary angioplasty at the time of initial cardiac
catheterization: “ad hoc” angioplasty possibilities and challenges.
Cathet Cardiovasc Diagn 1986;12:213-4.
822. Barnathan ES, Schwartz JS, Taylor L, et al. Aspirin and dipyridamole
in the prevention of acute coronary thrombosis complicating
coronary angioplasty. Circulation 1987;76:125-34.
823. Blankenship JC, Mishkel GJ, Chambers CE, et al. Ad Hoc Coronary
Intervention. Cathet Cardiovasc Intervent 2000;49:130-4.
824. Blankenship JC, Islam MA, Wood GC, Iliadis EA. Angiographic
adverse events during percutaneous coronary intervention fail to
predict creatine kinase-MB elevation. Catheter Cardiovasc Interv
2004;63:31-41.
825. Pamboukian SV, Costanzo MR. Transplant Coronary
Vasculopathy. Curr Treat Options Cardiovasc Med 2001;3:55-63.
826. Halle AA3, Wilson RF, Massin EK, et al. Coronary angioplasty in
cardiac transplant patients: results of a multicenter study.
Circulation 1992;86:458-62.
827. Redonnet M, Tron C, Koning R, et al. Coronary angioplasty and
stenting in cardiac allograft vasculopathy following heart transplantation.
Transplant Proc 2000;32:463-5.
828. Heublein B, Pethig K, Maass C, Wahlers T, Haverich A. Coronary
artery stenting in cardiac allograft vascular disease. Am Heart J
1997;134:930-8.
829. Benza RL, Zoghbi GJ, Tallaj J, et al. Palliation of allograft vasculopathy
with transluminal angioplasty: a decade of experience.
J Am Coll Cardiol 2004;43:1973-81.
830. Sandhu JS, Uretsky BF, Reddy PS, et al. Potential limitations of
percutaneous transluminal coronary angioplasty in heart transplant
recipients. Am J Cardiol 1992;69:1234-7.
831. Swan JW, Norell M, Yacoub M, Mitchell AG, Ilsley C. Coronary
angioplasty in cardiac transplant recipients. Eur Heart J 1993;
14:65-70.
832. von Scheidt W, Uberfuhr P, Reichart B, Steinbeck G. The role of
PTCA in the management of focal critical lesions in transplant
coronary artery disease. Transplant Proc 1995;27:1936-8.
833. Pande AK, Gosselin G, Rashdan I, Carrier M, Leung TK, Bonan
R. Coronary angioplasty in the treatment of post-cardiac transplant
coronary artery disease. J Invas Cardiol 1996;8:252-6.
834. Quigley PJ, Hlatky MA, Hinohara T, et al. Repeat percutaneous
transluminal coronary angioplasty and predictors of recurrent
restenosis. Am J Cardiol 1989;63:409-13.
835. Bauters C, LaBlanche JM, Leroy F, Bertrand ME. Treatment of
first restenosis by recurrent angioplasty: immediate results and
angiographic follow-up after 6 months. Arch Mal Coeur Vaiss
1992;85:1515-20.
836. Glazier JJ, Varricchione TR, Ryan TJ, Ruocco NA, Jacobs AK,
Faxon DP. Factors predicting recurrent restenosis after percutaneous
transluminal coronary balloon angioplasty. Am J Cardiol
1989;63:902-5.
837. Teirstein PS, Hoover CA, Ligon RW, et al. Repeat coronary
angioplasty: efficacy of a third angioplasty for a second restenosis.
J Am Coll Cardiol 1989;13:291-6.
838. Deligonul U, Vandormael M, Kern MJ, Galan K. Repeat coronary
angioplasty for restenosis: results and predictors of follow-up
clinical events. Am Heart J 1989;117:997-1002.
839. Bauters C, LaBlanche JM, McFadden EP, Leroy F, Bertrand ME.
Clinical characteristics and angiographic follow-up of patients
undergoing early or late repeat dilation for a first restenosis. J Am
Coll Cardiol 1992;20:845-8.
840. Bauters C, LaBlanche JM, Leroy F, Bertrand ME. Morphological
changes of coronary stenosis after repeated balloon angioplasties:
a quantitative angiographic study. Cathet Cardiovasc Diagn 1991;
24:158-60.
841. Henderson RA, Pipilis A, Cooke R, Timmis AD, Sowton E.
Angiographic morphology of recurrent stenoses after percutaneous
transluminal coronary angioplasty: are lesions longer at
restenosis? Int J Card Imaging 1990;6:77-84.
842. Kitazume H, Ichiro K, Iwama T, Ageishi Y. Repeat coronary
angioplasty as the treatment of choice for restenosis. Am Heart J
1996;132:711-5.
843. Reeder GS, Bresnahan JF, Holmes DR Jr, Litvack F. Excimer
laser coronary angioplasty: results in restenosis versus de novo
coronary lesions. Excimer Laser Coronary Angioplasty
Investigators. Cathet Cardiovasc Diagn 1992;25:195-9.
844. Erbel R, Haude M, Hopp HW, et al. Coronary-artery stenting
compared with balloon angioplasty for restenosis after initial balloon
angioplasty. Restenosis Stent Study Group [see comments].
N Engl J Med 1998;339:1672-8.
845. Serruys PW, Emanuelsson H, van der Giessen W, et al. Heparincoated
Palmaz-Schatz stents in human coronary arteries: early outcome
of the Benestent-II Pilot Study. Circulation 1996;93:412-22.
846. Dussaillant GR, Mintz GS, Pichard AD, et al. Small stent size and
intimal hyperplasia contribute to restenosis: a volumetric
intravascular ultrasound analysis. J Am Coll Cardiol 1995;26:
720-4.
847. Serruys PW, Kay IP, Disco C, Deshpande NV, de Feyter PJ.
Periprocedural quantitative coronary angiography after Palmaz-
Schatz stent implantation predicts the restenosis rate at six
months: results of a meta-analysis of the BElgian NEtherlands
Stent study (BENESTENT) I, BENESTENT II Pilot, BENES-
TENT II and MUSIC trials. Multicenter Ultrasound Stent In
Coronaries. J Am Coll Cardiol 1999;34:1067-74.